Thyroid cancer review 2: management of differentiated thyroid cancers

@article{Nix2005ThyroidCR,
  title={Thyroid cancer review 2: management of differentiated thyroid cancers},
  author={Paul Nix and A R Nicolaides and Andrew P. Coatesworth},
  journal={International Journal of Clinical Practice},
  year={2005},
  volume={59}
}
This is the second review article on thyroid cancer dealing with the common differentiated types that comprise 90% of thyroid cancers. Despite clinical management guidelines offered by a number of organisations including the British Association of Otolaryngologists and Head and Neck Surgeon, The British Thyroid Association, The American Association Of Endocrinologists, The American Thyroid Association and the National Cancer Centre Network, debate regarding the management of differentiated… 
Management of papillary and follicular (differentiated) thyroid carcinoma-an update
TLDR
The basis of surgical treatment of differentiated thyroid cancer is reviewed and the evidences supporting the surgical options are assessed.
PET/CT in the management of thyroid cancers.
TLDR
PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers, and its evolving value is summarized.
" Role of FNAC in Diagnosing Thyroid Neoplasms -A Retrospective Study "
TLDR
The aim of this study is to know the prevalence of thyroid cancer in the past five years and the role of FNAC in its diagnosis as well as knowing the limitations ofFNAC in the definitive diagnosis of malignant neoplasm of the thyroid gland.
Thyroid nodule as a first manifestation of Hodgkin lymphoma–report of two cases and literature review
TLDR
Two cases of HL, at baseline manifesting as a thyroid lesion, are presented: first patient, 29-year-old pregnant female, initially suspected for metastatic medullary thyroid cancer, was eventually diagnosed with mixed cellularity type of thyroid HL, and second patient, 22- year-old woman, was in the end diagnosed with an extra-lymphatic classical HL of the thyroid.
Primary Thyroid Lymphoma as A Manifestation of Rapidly Growing Thyroid Causing Progressive Respiratory Distress
TLDR
A 73-year old man with rapidly glowing neck mass had a 6-year history of hypothyroidism-associated with Hashimoto thyroiditis and maintained L-thyroxine replacement and an incisional biopsy of the thyroid grand revealed diffuse large B cell non-Hodgkin’s lymphoma with germinal center B-cell subtype.
Clinical characteristics and molecular pathology of skull ectopic thyroid cancer.
TLDR
The clinical characteristics and possible molecular mechanisms of this rare disease, which has not been reported in 50 years of literatures in foreign countries, and the PI3K gene, predicted to be a key crossing gene of the above three signaling pathways, are investigated.
Prevalence of Thyroid Nodules and Its Relationship with Iodine Status in Shanghai: a Population-based Study.
  • Jun Song, S. Zou, Fan Wu
  • Medicine, Biology
    Biomedical and environmental sciences : BES
  • 2016
TLDR
The relationship between UIC and prevalence of TNs is U-shaped, with an increase in risk when the UIC was <140 μg/L and >400 μg/ L and very low or high UIC levels need attention and correction.
The most common factors influencing on quality of life of thyroid cancer patients after thyroid hormone withdrawal.
TLDR
The results of QOL-Thyroid questionnaire help to identify high-risk areas in patients' lives that are negatively affected by hormone withdrawal, and a positive impact on patients' recovery could be achieved by directing attention to most expressed difficulties noted in this questionnaire.
Recurrence of differentiated thyroid cancer: significance of ultrasound examination and ultrasound-guided fine-needle aspiration biopsy in the diagnosis of recurrence at thyroid bed and regional lymph nodes
TLDR
The role of ultrasound and ultrasound-guided fine-needle aspiration biopsy in the confirmation of differentiated thyroid cancer recurrence has not been differentiated for thyroid bed and regional lymph nodes and for assessing clinical behaviour adequately.
VANDETANIB (CAPRELSA): AN ANTI-CANCER DRUG THAT IS USED FOR THE TREATMENT OF MEDULLARY THYROID CANCER (MTC)
TLDR
Vandetanib improved progression-free survival compared with placebo and the most common reported adverse reactions are diarrhea, rash, acne, nausea, hypertension, headache, fatigue, decreased appetite, abdominal pain, hypocalcemia, hypoglycemia and increased alanine transaminase (ALT), QTc prolongation.
...
1
2
...

References

SHOWING 1-10 OF 29 REFERENCES
The British Thyroid Association guidelines for the management of thyroid cancer in adults
  • J. Watkinson
  • Medicine, Biology
    Nuclear medicine communications
  • 2004
TLDR
Thyroid nodular disease is common in the UK and 50% of nodules are considered solitary, but the problem increases with age and the number of solitary nodules is more common in women.
Advances in the diagnosis and management of thyroid neoplasms
  • J. Bi, B. Lu
  • Medicine
    Current opinion in oncology
  • 2000
TLDR
Given the gradual perfection of surgical technique and reduction in complication rates, near-total and total thyroidectomy should be offered to patients with well-differentiated carcinoma.
Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma.
  • S. Sherman
  • Medicine
    Seminars in surgical oncology
  • 1999
TLDR
Eight of the most commonly used clinicopathologic classification approaches for differentiated thyroid carcinoma are described, along with results of recent comparative analyses of multiple schemes.
Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.
TLDR
The approach to treatment of papillary and follicular cancer is usually very similar, and DTC is more likely to be completely resected and ablated with iodine-131 (I), an approach that has become more popular in the past several decades when discovered at an early stage.
The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients.
TLDR
Treatment with radioactive iodine was the single most powerful prognostic indicator for increased disease-free interval (P less than 0.001) and that its use significantly increased survival as well and no benefit was obtained from treatment with external radiotherapy.
An overview of the management of papillary and follicular thyroid carcinoma.
  • E. Mazzaferri
  • Medicine
    Thyroid : official journal of the American Thyroid Association
  • 1999
TLDR
It is believed that an aggressive approach to initial management and follow-up may render nearly 90% of the patients permanently free of disease.
Papillary Thyroid Carcinoma
TLDR
Because papillary carcinomas are nonfunctional and findings on radiography are nonspecific, fine-needle aspiration plays an important role in the initial eva luation of any thyroid nodule and as aguide to subsequent therapy.
Intermediate-risk group for differentiated carcinoma of thyroid.
TLDR
A retrospective review of previously untreated patients with differentiated carcinoma of thyroid treated during a period of 55 years identifies a distinct intermediate-risk category that includes low-risk patients with high-risk tumor or high- risk patients with low- risk tumor.
High Prevalence of Occult Papillary Thyroid Carcinoma in a Surgical Series for Benign Thyroid Disease
TLDR
It is suggested that lobectomy plus T4 treatment may be considered an adequate therapeutic approach in patients with occult papillary thyroid carcinoma.
Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer.
  • H. Maxon, H. Smith
  • Medicine, Biology
    Endocrinology and metabolism clinics of North America
  • 1990
...
1
2
3
...